CBIZ (CBZ) Stock Valuation Check After Rebound And Insider Buying
CBIZ, Inc. CBZ | 0.00 |
Conference spotlight puts CBIZ in focus
CBIZ (CBZ) is back in the spotlight after presenting at the 46th Annual William Blair Growth Stock Conference in Chicago, drawing attention to a stock that has been rebounding from long term lows.
Recent coverage links the move in CBIZ shares to improving technical signals, a wide gap to some valuation estimates, and insider buying, while still flagging risks around AI disruption concerns and acquisition related leverage.
The recent conference appearance and insider buying have come alongside a sharp short term rebound, with a 30 day share price return of 21.92% and 90 day share price return of 37.15%. However, the 1 year total shareholder return remains down 48.79%, suggesting momentum has picked up after a tough period.
If this rebound has you thinking about other potential opportunities, it could be a good moment to widen your research and check out 20 top founder-led companies
With CBIZ trading at US$35.26 against a stated US$41.00 analyst target and a much higher intrinsic estimate, and with insider buying in the mix, is the stock genuinely undervalued, or are markets already accounting for potential future growth in the current price?
Most Popular Narrative: 14% Undervalued
CBIZ's most followed valuation story puts fair value at $41, above the last close of $35.26, and builds that gap on very specific growth and profitability assumptions.
The Marcum acquisition has significantly expanded CBIZ's client base, increased scale, and strengthened capabilities in core tax, accounting, and advisory services, enabling the firm to leverage cross-selling, deepen client relationships, and improve its competitive position in target middle market segments. This is expected to fuel higher future revenue growth and structural margin expansion as integration synergies are realized.
Curious what underpins that valuation gap? The narrative leans on steady top line progress, fatter margins, and a future earnings multiple that sits below many industry peers. The tension lies in how those pieces fit together.
Discount rate used in the narrative: 9.6%.
Result: Fair Value of $41 (UNDERVALUED)
However, investors still need to weigh pricing pressure on key services and the higher leverage from the Marcum deal, either of which could limit the upside case.
Next Steps
With sentiment pulled between fresh optimism and lingering concern, this is a good moment to move quickly, review the key data, and weigh the 4 key rewards and 1 important warning sign.
Looking for more investment ideas?
If CBIZ has sharpened your focus, do not stop here. Broaden your watchlist now so you are not the one hearing about the next move too late.
- Tap into potential mispricings by scanning 44 high quality undervalued stocks and see which stocks currently trade below their implied quality.
- Prioritize resilience and sleep easier at night by using the 71 resilient stocks with low risk scores to spot companies with steadier profiles.
- Hunt for underfollowed opportunities before the crowd spots them by running the screener containing 20 high quality undiscovered gems.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
